Clinical management of metastatic colorectal cancer in the era of precision medicine
F Ciardiello, D Ciardiello, G Martini… - CA: a cancer journal …, 2022 - Wiley Online Library
Colorectal cancer (CRC) represents approximately 10% of all cancers and is the second
most common cause of cancer deaths. Initial clinical presentation as metastatic CRC …
most common cause of cancer deaths. Initial clinical presentation as metastatic CRC …
[HTML][HTML] Overcoming barriers to patient adherence: the case for developing innovative drug delivery systems
TH Baryakova, BH Pogostin, R Langer… - Nature Reviews Drug …, 2023 - nature.com
Poor medication adherence is a pervasive issue with considerable health and
socioeconomic consequences. Although the underlying reasons are generally understood …
socioeconomic consequences. Although the underlying reasons are generally understood …
[PDF][PDF] 2016 年中国恶性肿瘤流行情况分析
郑荣寿, 张思维, 孙可欣, 陈茹, 王少明… - 中华肿瘤 …, 2023 - 11871494.s21i.faimallusr.com
目的根据全国各肿瘤登记处上报至全国肿瘤登记中心的2016 年恶性肿瘤登记数据, 估计2016
年中国恶性肿瘤流行特征. 方法根据全国肿瘤登记中心对肿瘤登记数据的质量控制和审核流程 …
年中国恶性肿瘤流行特征. 方法根据全国肿瘤登记中心对肿瘤登记数据的质量控制和审核流程 …
[HTML][HTML] The global burden of cancer attributable to risk factors, 2010–19: a systematic analysis for the Global Burden of Disease Study 2019
KB Tran, JJ Lang, K Compton, R Xu, AR Acheson… - The Lancet, 2022 - thelancet.com
Background Understanding the magnitude of cancer burden attributable to potentially
modifiable risk factors is crucial for development of effective prevention and mitigation …
modifiable risk factors is crucial for development of effective prevention and mitigation …
[HTML][HTML] Global, regional, and national burden of hepatitis B, 1990–2019: a systematic analysis for the Global Burden of Disease Study 2019
BS Sheena, L Hiebert, H Han, H Ippolito… - The lancet …, 2022 - thelancet.com
Background Combating viral hepatitis is part of the UN Sustainable Development Goals
(SDGs), and WHO has put forth hepatitis B elimination targets in its Global Health Sector …
(SDGs), and WHO has put forth hepatitis B elimination targets in its Global Health Sector …
[HTML][HTML] Age–sex differences in the global burden of lower respiratory infections and risk factors, 1990–2019: results from the Global Burden of Disease Study 2019
HH Kyu, A Vongpradith, SB Sirota… - The Lancet infectious …, 2022 - thelancet.com
Background The global burden of lower respiratory infections (LRIs) and corresponding risk
factors in children older than 5 years and adults has not been studied as comprehensively …
factors in children older than 5 years and adults has not been studied as comprehensively …
[HTML][HTML] Nanodelivery of nucleic acids
There is growing need for a safe, efficient, specific and non-pathogenic means for delivery of
gene therapy materials. Nanomaterials for nucleic acid delivery offer an unprecedented …
gene therapy materials. Nanomaterials for nucleic acid delivery offer an unprecedented …
[HTML][HTML] Global, regional, and national burden of colorectal cancer and its risk factors, 1990–2019: a systematic analysis for the Global Burden of Disease Study 2019
R Sharma, M Abbasi-Kangevari… - The lancet …, 2022 - thelancet.com
Background Colorectal cancer is the third leading cause of cancer deaths worldwide. Given
the recent increasing trends in colorectal cancer incidence globally, up-to-date information …
the recent increasing trends in colorectal cancer incidence globally, up-to-date information …
Updated epidemiology of gastrointestinal cancers in East Asia
Globally, gastrointestinal cancers represent more than one-fourth of all cancer incidence
and one-third of cancer-related mortality. Although there has been much progress in …
and one-third of cancer-related mortality. Although there has been much progress in …
The global burden of liver disease
Chronic liver disease (CLD) and its associated complications (cirrhosis and liver cancer)
cause significant mortality, morbidity, and economic burden. Published data from the World …
cause significant mortality, morbidity, and economic burden. Published data from the World …